Table 1

The effect of topical LY354740 application on RLFs’ peak firing rates, slopes, and thresholds

TermStatisticp value
Peak firing rate
 Overall ANOVA
  DrugF(1,253) = 80.8<0.0001
  ClusterF(2,28) = 2.80.07
  Drug-cluster interactionF(2,253) = 44.3<0.0001
 Pairwise comparisons with clusters
  Cluster #1: pre-drug–post-drugt(253) = 10.7<0.0001
  Cluster #2: pre-drug–post-drugt(253) = 5.9<0.0001
  Cluster #3: pre-drug–post-drugt(253) = −1.80.07
Slope
 Overall ANOVA
  DrugF(1,253) = 13.9<0.001
  ClusterF(2,28) = 0.90.4
  Drug-cluster interactionF(2,253) = 5.6<0.01
 Pairwise comparisons with clusters
  Cluster #1: pre-drug–post-drugt(253) = 2.5<0.05
  Cluster #2: pre-drug–post-drugt(253) = 4.3<0.0001
  Cluster #3: pre-drug–post-drugt(253) = −0.40.7
Threshold
 Overall ANOVA
  DrugF(1,253) = 47.0<0.0001
  ClusterF(2,28) = 0.80.4
  Drug-cluster interactionF(2,253) = 11.1<0.0001
 Pairwise comparisons with clusters
  Cluster #1: pre-drug–post-drugt(253) = −6.6<0.0001
  Cluster #2: pre-drug–post-drugt(253) = −4.4<0.0001
  Cluster #3: pre-drug–post-drugt(253) = −0.50.6
  • The drug had a significant effect on all three dependent variables in clusters #1 and #2, but not in cluster #3, neurons. Significant p values are highlighted in bold.